ImmuneWatch
ImmuneWatch provides software to annotate T-cell receptor (TCR) sequences and identify therapy-, vaccine-, or pathogen-specific TCRs for therapeutics and diagnostics development.
ImmuneWatch offers a software platform that annotates the epitope specificity of T-cell receptor sequences, converting TCR repertoires into clinically actionable data. The company provides ImmuneWatch DETECT, which extracts therapy-, vaccine-, or pathogen-specific TCRs from TCR repertoires, available as a machine learning platform for on-premises deployment or through direct collaboration with ImmuneWatch.
Key People
Sander Wuyts - CEO and Co-founder
In the media1
Sander Wuyts discusses how Nick Goldman from the European Bioinformatics Institute created a proof of concept demonstrating that computer files encoded in binary (zeros and ones) could be translated into DNA sequences using a four-base encoding system (A, C, G, T) and physically printed onto DNA molecules.